We first found that an altered placental fatty acid metabolism is associated with enhanced maternal cytokines levels (essentially IL‐6) present in serum of GDM women in late gestation, including a diminished placental fatty acid β‐oxidation capacity and an excess FFA accumulation in form of TGs. The gene discussed is IL6; the disease is gestational diabetes.